Cassia Cearley - 30 Jan 2023 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Business Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Jan 2023
Net transactions value
+$21,086
Form type
4
Filing time
31 Jan 2023, 15:19:57 UTC
Previous filing
14 Nov 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $21,086 +25,102 +19% $0.8400* 156,840 30 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -25,102 -91% $0.000000 2,511 30 Jan 2023 Common Stock 25,102 $0.8400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on 12/2/2020, and 1/48th of the shares subject to the option vest monthly thereafter.